Cultivating Immunity: Navigating the Plant-Based Vaccines Market Landscape || Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Plant-Based Vaccines Global Market Report 2023 identifies the high prevalence of infectious diseases is expected to propel the growth of the plant-based vaccine market going forward. Infectious diseases refer to ailments from germs like bacteria, viruses, fungi, or parasites. Plant-based vaccines, employed in traditional and modern medicine for various illnesses, including infectious diseases, can create secure, effective, stable, and reasonably priced prophylactics, vaccines, and medications. For instance, in October 2022, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based global health agency, the global incidence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 population.

The global plant-based vaccines market is expected to grow from $1.38 billion in 2022 to $1.52 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The plant-based vaccines market is expected to reach $2.24 billion in 2027 at a CAGR of 10.1%.

Download Free Sample Of Plant-Based Vaccines Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=12144&type=smp

Major competitors in the plant-based vaccines market are Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc.

A key trend in the plant-based vaccines market includes product innovation. Major companies operating in the plant-based vaccine market are focused on developing innovative products to sustain their position in the market. For instance, in February 2022, Medicago Inc., a Canada-based biopharmaceutical company, and GSK PLC, a UK-based pharmaceutical and biotechnology company, announced that Health Canada had approved COVIFENZ, the COVID-19 vaccine.

Read More On The Global Plant-Based Vaccines Market Report Here: https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

The plant-based vaccines market is segmented -

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

4) By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the plant-based vaccines market.

The Business Research Company's "Global Plant-Based Vaccines Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Plant-Based Vaccines Market Report Here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

The Table Of Content For The Plant-Based Vaccines Market Include:
1. Executive Summary
2. Plant-Based Vaccines Market Characteristic
3. Plant-Based Vaccines Market Trends And Strategies
4. Plant-Based Vaccines Market - Macro Economic Scenario
5. Plant-Based Vaccines Market Size And Growth
……………
27. Plant-Based Vaccines Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Plant-Based Vaccines Market
29. Plant-Based Vaccines Market Future Outlook And Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.